Koen E Groeneweg

6PUBLICATIONS
27CO-AUTHORS
Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 26, 2023
HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.

Suzanne Bezstarosti, Soufian Meziyerh, Marlies E J Reinders

|Dec 16, 2021
Cardiovascular Effects of Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study.

Maria Chiara Meucci, Marlies E J Reinders, Koen E Groeneweg

|Feb 10, 2021
Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study.

Marlies E J Reinders, Koen E Groeneweg, Sanne H Hendriks

|Aug 09, 2020
Circulating Long Noncoding RNA LNC-EPHA6 Associates with Acute Rejection after Kidney Transplantation.

Koen E Groeneweg, Jacques M G J Duijs, Barend W Florijn

|May 01, 2020
Diabetic nephropathy alters circulating long noncoding RNA levels that normalize following simultaneous pancreas-kidney transplantation.

Koen E Groeneweg, Yu Wah Au, Jacques M G J Duijs

|Apr 12, 2020
Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study.

Geertje J Dreyer, Koen E Groeneweg, Sebastiaan Heidt

Pageof 1

Frequent Collaborators

4 joint publications

Marlies E J Reinders

3 joint publications

Sebastiaan Heidt

2 joint publications

Geertje J Dreyer

2 joint publications

Barend W Florijn